Viral lymphomagenesis: from pathophysiology to the rationale for novel therapies.
about
Human immunodeficiency virus-associated lymphomas in the antiretroviral therapy era: Analysis of the National Cancer Data Base.EBV-driven B-cell lymphoproliferative disorders: from biology, classification and differential diagnosis to clinical management.Role of Feline Immunodeficiency Virus in Lymphomagenesis--Going Alone or Colluding?Intimate cross-talk between cancer cells and the tumor microenvironment of B-cell lymphomas: The key role of exosomes.Loss of T-Cell Multifunctionality and TCR-Vβ Repertoire Against Epstein-Barr Virus Is Associated With Worse Prognosis and Clinical Parameters in HIV Patients
P2860
Viral lymphomagenesis: from pathophysiology to the rationale for novel therapies.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Viral lymphomagenesis: from pathophysiology to the rationale for novel therapies.
@en
type
label
Viral lymphomagenesis: from pathophysiology to the rationale for novel therapies.
@en
prefLabel
Viral lymphomagenesis: from pathophysiology to the rationale for novel therapies.
@en
P2860
P356
P1476
Viral lymphomagenesis: from pathophysiology to the rationale for novel therapies.
@en
P2093
Emmanuel Apor
Kenneth D Bishop
P2860
P304
P356
10.1111/BJH.12788
P407
P577
2014-02-18T00:00:00Z